Lung Cancer Screening and Prevention Act of 2025

This legislative proposal aims to significantly broaden the scope of lung cancer screening services covered under the Medicare program by amending Section 1834(n) of the Social Security Act. It grants the Secretary of Health and Human Services new authority to authorize coverage for additional lung cancer screening tests. The core provision enables the Secretary to include tests that are cleared or approved by the Food and Drug Administration (FDA) as preventive services, beyond those currently covered. The Secretary will determine the appropriate individuals for these screenings, along with their frequency and payment limits, after consulting with relevant organizations. While utilizing the established national coverage determination process, the bill streamlines it by removing a specific determination requirement, allowing for more flexibility in adopting new screening technologies. This ensures that Medicare beneficiaries could have access to a wider range of advanced lung cancer detection methods. The amendments will take effect upon the bill's enactment, applying to preventive services covered under Medicare Part B.